ARCHIVES

Study of Dlurectic Use As Renal Cell Cancer Risk Gets Concept Approval

This article is from The Cancer Letter archive.

Vol. 15 No. 11 | March 10, 1989

Download PDF Visit The Full Archive

Related Articles

Study Identifies Risk Factors To Predict Contralateral Cancer

February 27, 2009

ACCC Seeks Expanded Backing For CHOP, Other Community Cancer Programs

November 7, 1980

Committee Drafts QRA Definition

November 19, 1982

Unclear Whether Insurance Will Cover AACR Losses

April 25, 2003

Smokeless Tobacco Warning Bill May Go To House Floor

January 24, 1986

ODAC Meets at ASCO, Recommends Approval Of Dasatinib For CML.

June 9, 2006